Medicine recalls
|
| |
| Singapore: Recall of one batch of Ikervis 1mg／ml Eye Drop Emulsion |
| |
Health Sciences Authority (HSA) announces retail-level recall of one batch of Ikervis 1mg/ml Eye Drop Emulsion (ciclosporin) (batch 1L49) due to a manufacturing issue that may result in the eye drop being less effective. During routine stability studies, it was found that Ikervis (batch 1L49P) did not meet the active ingredient targeted concentration and presented a lower concentration due to crystallisation of the active ingredient. Patients who use the affected eye drops may get lesser relief of their symptoms associated with severe dry eye syndrome.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-one-batch-of-ikervis-1mg-ml-eye-drop-emulsion
In Hong Kong, Ikervis Eye Drops, Emulsion 1mg/ml (HK-65076) is a pharmaceutical product registered by Santen Pharmaceutical (Hong Kong) Limited (Santen), and is a prescription-only medicine. As confirmed with Santen, 1L49 is the parent lot of the product, while 1L49P is the sub-lot supplied to Singapore, the parent lot of 1L49 and all its sub-lots have not been imported into Hong Kong.
Ends/Friday, Aug 27, 2021
Issued at HKT 15:00
|
| |
|
